Chemokine CCL2 and its receptor CCR2 in different age groups of patients with COVID-19
Taken together, the findings demonstrate that CCL2 and CCR2 are upregulated in COVID-19 patients at protein and mRNA levels, respectively. Therefore, the CCL2/CCR2 axis may be a potential therapeutic target in order to improve patient outcomes.
Authors
- Mitra Abbasifard (ORCID: https://orcid.org/0000-0003-4670-7127)
- Hossein Khorramdelazad (ORCID: https://orcid.org/0000-0002-0653-2724)
- Mehdi Kafi
- Vahid Bagheri (ORCID: https://orcid.org/0000-0002-0114-5370)
Institutions
- Rafsanjan University of Medical Sciences (IR)
Publication Details
- Journal
- BMC Immunology
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1186/s12865-024-00662-8
- Citations
- 4
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.56
Funders
- Rafsanjan University of Medical Sciences